Editorial: Beyond Viral Eradication—Cardiometabolic Risk and Cardiovascular Outcomes After <scp>SVR</scp> in Chronic Hepatitis C. Authors' Reply

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2026-02-05
DOI
https://doi.org/10.1111/apt.70567
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Editorial: Beyond Viral Eradication—Cardiometabolic Risk and Cardiovascular Outcomes After SVR in Chronic Hepatitis C. Authors' Reply

ML Yu, Pei‐Chien Tsai, Jee‐Fu Huang
Alimentary Pharmacology & Therapeutics
Liver Disease Diagnosis and Treatment
article

Editorial: Beyond Viral Eradication—Cardiometabolic Risk and Cardiovascular Outcomes After SVR in Chronic Hepatitis C. Authors' Reply

ML Yu, Pei‐Chien Tsai, Jee‐Fu Huang
article en

Abstract

No abstract available for this paper.
Alimentary Pharmacology & TherapeuticsVol. 63(8)
Kaohsiung Medical University (TW), Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
Good health and well-being
Openalex Percentile: Top 64%
Liver Disease Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Editorial: Beyond Viral Eradication—Cardiometabolic Risk and Cardiovascular Outcomes After <scp>SVR</scp> in Chronic Hepatitis C. Authors' Reply — ML Yu, Pei‐Chien Tsai, et al. · Alimentary Pharmacology & Therapeutics (2026) | TGRS Research Map | TGRS